CoChat

The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells

Open access
Țigu, Adrian Bogdan, Toma, Vlad-Alexandru, Moț, Augustin Cătălin, Jurj, Ancuța, Moldovan, Cristian Silviu, Fischer-Fodor, Eva, Berindan-Neagoe, Ioana, Pârvu, Marcel · 2020 · Molecules
Cited by 63

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

5-fluorouracil (5-FU) is an anticancer drug used to inhibit the proliferation of many different tumor cells. Since severe events are associated with this compound, its combination with different anticancer drugs or adjuvants would allow the use of a significantly lower dose of 5-FU. In this study, we highlighted that the combination of allicin with 5-FU inhibited the cell migration and proliferation of colorectal and lung cancer cells. 5-FU inhibited cell growth with a similar inhibitory concentration for both normal and tumor cells (~200µM), while allicin showed different inhibitory concentrations. With an IC50 of 8.625 µM, lung cancer cells were the most sensitive to allicin. Compared to 5-FU and allicin single-agent treatments, the co-treatment showed a reduced viability rate, with p < 0.05. The morphological changes were visible on all three cell lines, indicating that the treatment inhibited the proliferation of both normal and tumor cells. We highlighted different cell death mechanisms—apoptosis for lung cancer and a non-apoptotic cell death for colorectal cancer. The synergistic antitumor effect of 5-FU combined with allicin was visible against lung and colorectal carcinoma cells. Better results were obtained when a lower concentration of 5-FU was combined with allicin than the single-agent treatment at IC50.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules25081947

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 49

  1. Tomeh, M.A., Hadianamrei, R., and Zhao, X. (2019). A Review of Curcumin and Its Derivatives as Anticancer Agents. Int. J. Mol. Sci., 20. · DOI · Paper page
  2. Canada, 2019, Release notice—Canadian Cancer Statistics 2019, Heal. Promot. Chronic Dis. Prev. Can., 39, 255, 10.24095/hpcdp.39.8/9.04 · DOI
  3. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 68, 394, 10.3322/caac.21492 · DOI · Paper page
  4. Yang, 2017, Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- κB Signaling Pathways, J. Cancer, 8, 3697, 10.7150/jca.20196 · DOI
  5. Lim, 2019, Sex-Dependent Adverse Drug Reactions to 5-Fluorouracil in Colorectal Cancer, Boil. Pharm. Bull., 42, 594, 10.1248/bpb.b18-00707 · DOI
  6. Majounie, 2019, Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant, Mol. Case Stud., 6, 6
  7. Zou, 2016, Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway, J. Pharmacol. Sci., 131, 233, 10.1016/j.jphs.2016.04.017 · DOI
  8. Lichota, A., and Gwozdzinski, K. (2018). Anticancer Activity of Natural Compounds from Plant and Marine Environment. Int. J. Mol. Sci., 19. · DOI · Paper page
  9. Petrovic, V., Nepal, A., Olaisen, C., Bachke, S., Hira, J., Søgaard, C.K., Røst, L.M., Misund, K., Andreassen, T., and Melø, T.M. (2018). Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress. Nutrients, 10. · DOI
  10. Moon, 2018, A rich source of potential bioactive compounds with anticancer activities by Catharanthus roseus cambium meristematic stem cell cultures, J. Ethnopharmacol., 217, 107, 10.1016/j.jep.2018.02.021 · DOI
  11. Chen, 2018, Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma, Cell. Physiol. Biochem., 47, 641, 10.1159/000490019 · doi:10.1159/000490019
  12. Mikaili, 2013, Therapeutic Uses and Pharmacological Properties of Garlic, Shallot, and Their Biologically Active Compounds, Iran J. Basic Med. Sci., 16, 1031
  13. Tsubura, 2011, Anticancer effects of garlic and garlic-derived compounds for breast cancer control, Anti-Cancer Agents Med. Chem., 11, 249, 10.2174/187152011795347441 · doi:10.2174/187152011795347441
  14. Rajput, 2012, Antitumor promoting potential of selected phytochemicals derived from spices, Eur. J. Cancer Prev., 21, 205, 10.1097/CEJ.0b013e32834a7f0c · DOI
  15. Zhang, 2018, Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2, Exp. Ther. Med., 17, 1523
  16. Li, 2018, Allicin induces apoptosis through activation of both intrinsic and extrinsic pathways in glioma cells, Mol. Med. Rep., 17, 5976
  17. Jiang, 2013, The Synergistic Anticancer Effect of Artesunate Combined with Allicin in Osteosarcoma Cell Line in Vitro and in Vivo, Asian Pac. J. Cancer Prev., 14, 4615, 10.7314/APJCP.2013.14.8.4615 · DOI
  18. Budisan, L., Gulei, D., Jurj, A., Braicu, C., Zanoaga, O., Cojocneanu, R., Pop, L., Raduly, L., Barbat, A., and Moldovan, A. (2019). Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies. Int. J. Mol. Sci., 20. · DOI
  19. Braicu, 2019, miR-181a/b therapy in lung cancer: Reality or myth?, Mol. Oncol., 13, 9, 10.1002/1878-0261.12420 · DOI
  20. Zhang, 2014, Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma, Int. J. Clin. Exp. Med., 7, 1190
  21. Pannu, 2015, Lung adenocarcinoma presenting with isolated ’chronic cough’ of 3 years duration-a cautionary tale, Respiratory Medicine Case Reports, 16, 157, 10.1016/j.rmcr.2015.10.005 · doi:10.1016/j.rmcr.2015.10.005
  22. Mármol, I., Sánchez-De-Diego, C., Dieste, A.P., Cerrada, E., and Yoldi, M.R. (2017). Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int. J. Mol. Sci., 18. · DOI · Paper page
  23. Huang, 2017, A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer, Biomedicine, 7, 23, 10.1051/bmdcn/2017070423 · DOI · Paper page
  24. Bracht, 2010, 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency, Br. J. Cancer, 103, 340, 10.1038/sj.bjc.6605780 · DOI · Paper page
  25. Zhao, 2014, Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism, Tumor Boil., 35, 12305, 10.1007/s13277-014-2543-3 · DOI
  26. He, 2017, Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation, J. Cancer, 8, 1187, 10.7150/jca.18171 · DOI · Paper page
  27. Braicu, 2017, Nutrigenomics in cancer: Revisiting the effects of natural compounds, Semin. Cancer Boil., 46, 84, 10.1016/j.semcancer.2017.06.011 · DOI
  28. Budisan, L., Gulei, D., Zanoaga, O., Irimie-Aghiorghiesei, A.I., Chira, S., Braicu, C., Gherman, C.D., and Berindan-Neagoe, I. (2017). Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer. Int. J. Mol. Sci., 18. · DOI
  29. Nabavi, 2018, Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials, Cancer Lett., 434, 101, 10.1016/j.canlet.2018.07.018 · DOI
  30. Moosavi, 2018, Phytochemicals as potent modulators of autophagy for cancer therapy, Cancer Lett., 424, 46, 10.1016/j.canlet.2018.02.030 · DOI
  31. Toma, V.A., Ţigu, A.B., Farcaș, A.D., Sevastre, B., Taulescu, M., Gherman, A.M.R., Roman, I., Fischer-Fodor, E., and Pârvu, M. (2019). New Aspects Towards a Molecular Understanding of the Allicin Immunostimulatory Mechanism via Colec12, MARCO, and SCARB1 Receptors. Int. J. Mol. Sci., 20. · DOI
  32. Kaschula, 2014, The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention, Anti-Cancer Agents Med. Chem., 14, 233, 10.2174/18715206113136660370 · DOI · Paper page
  33. Padiya, R., Chowdhury, D., Borkar, R., Srinivas, R., Bhadra, M.P., and Banerjee, S.K. (2014). Garlic Attenuates Cardiac Oxidative Stress via Activation of PI3K/AKT/Nrf2-Keap1 Pathway in Fructose-Fed Diabetic Rat. PLoS ONE, 9. · DOI
  34. Dhawan, 2005, Garlic supplementation prevents oxidative DNA damage in essential hypertension, Mol. Cell. Biochem., 275, 85, 10.1007/s11010-005-0824-2 · DOI
  35. Golan, 2010, Allicin Purified From Fresh Garlic Cloves Induces Apoptosis in Colon Cancer Cells Via Nrf2, Nutr. Cancer, 62, 947, 10.1080/01635581.2010.509837 · DOI · Paper page
  36. Chu, 2012, Allicin Induces p53-Mediated Autophagy in Hep G2 Human Liver Cancer Cells, J. Agric. Food Chem., 60, 8363, 10.1021/jf301298y · DOI
  37. Xiang, 2018, Allicin activates autophagic cell death to alleviate the malignant development of thyroid cancer, Exp. Ther. Med., 15, 3537
  38. Huang, 2017, Allicin inhibits the invasion of lung adenocarcinoma cells by altering tissue inhibitor of metalloproteinase/matrix metalloproteinase balance via reducing the activity of phosphoinositide 3-kinase/AKT signaling, Oncol. Lett., 14, 468, 10.3892/ol.2017.6129 · DOI
  39. Gruhlke, 2018, The human allicin-proteome: S-thioallylation of proteins by the garlic defence substance allicin and its biological effects, Free. Radic. Boil. Med., 131, 144, 10.1016/j.freeradbiomed.2018.11.022 · DOI
  40. Song, 2015, Allicin inhibits human renal clear cell carcinoma progression via suppressing HIF pathway, Int. J. Clin. Exp. Med., 8, 20573
  41. Xu, 2013, S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro, Acta Pharmacol. Sin., 35, 267, 10.1038/aps.2013.176 · DOI
  42. Bortner, 2007, Cell shrinkage and monovalent cation fluxes: Role in apoptosis, Arch. Biochem. Biophys., 462, 176, 10.1016/j.abb.2007.01.020 · DOI · Paper page
  43. Fulda, 2010, Cellular Stress Responses: Cell Survival and Cell Death, Int. J. Cell Boil., 2010, 1
  44. Oommen, 2004, Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells, Eur. J. Pharmacol., 485, 97, 10.1016/j.ejphar.2003.11.059 · DOI · Paper page
  45. Park, 2005, Caspase-independent cell death by allicin in human epithelial carcinoma cells: Involvement of PKA, Cancer Lett., 224, 123, 10.1016/j.canlet.2004.10.009 · DOI
  46. Pistritto, 2016, Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies, Aging, 8, 603, 10.18632/aging.100934 · DOI · Paper page
  47. Fox, 2016, Targeting cell death signalling in cancer: Minimising ’Collateral damage’, Br. J. Cancer, 115, 5, 10.1038/bjc.2016.111 · DOI
  48. Gruhlke, 2010, Allicin disrupts the cell’s electrochemical potential and induces apoptosis in yeast, Free. Radic. Boil. Med., 49, 1916, 10.1016/j.freeradbiomed.2010.09.019 · DOI
  49. Rafehi, H., Orlowski, C., Georgiadis, G.T., Ververis, K., El-Osta, A., and Karagiannis, T.C. (2011). Clonogenic Assay: Adherent Cells. J. Vis. Exp., e2573. · DOI · Paper page

Cited by

See all 63

Metadata

Authors
Țigu, A. B., Toma, V.-A., Moț, A. C., Jurj, A., Moldovan, C. S., Fischer-Fodor, E., Berindan-Neagoe, I., & Pârvu, M.
Venue
Molecules
Publisher
MDPI AG
Published
2020-04-22
Volume
25
Issue
8
Pages
1947
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3018735346
Cited by
63
References
7
FWCI
4.59
Type
journal article
Language
en
Open access
gold
Funders
UBB of Cluj-Napoca (Romania) by Grant to support competitiveness (Nr. AGC 30411 from 5.02.2020 (https://infocercetare.ubbcluj.ro/Proiecte/Proiecte/Edit?id=14721), Nr. AGC 30412 from 5.02.2020 (https://infocercetare.ubbcluj.ro/Proiecte/Proiecte/Edit?id=14722) and. Nr. AGC 30413 from 2020 (https://infocercetare.ubbcluj.ro)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.